CIK 0001799191
- Accelerated filer
- Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN STLNW DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 843562323
- Phone
- +1 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Common stock Nasdaq
- DFPH Common stock OTC
- 4 Grant or award Director acquired 80,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 56,000 shares (grant or award)
- 4 Grant or award Director acquired 52,000 shares (grant or award)
- 4 Grant or award Director acquired 56,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 44,000 shares (grant or award)
- 4 Returned to the company Chief Executive Officer returned 9,727 shares (to the company)
- 4 Returned to the company Chief Financial Officer returned 235 shares (to the company)
- 4 Returned to the company Chief Medical Officer returned 3,002 shares (to the company)
- 4 Other disposition Chief Medical Officer disposed of 28,398 shares (other)
- 4 Other disposition Director disposed of 50,620 shares (other)
- 4 Other disposition Chief Executive Officer disposed of 195,236 shares (other)
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 4 Other disposition 10% owner disposed of 16,333,241 shares (other)
- 4 Returned to the company Director returned 18,121 shares (to the company)
- 4 Returned to the company Director returned 19,526 shares (to the company)
- 4 Returned to the company Chief Executive Officer returned 11,173 shares (to the company)
- 4 Grant or award Chief Financial Officer acquired 151,459 shares (grant or award)
Page 6 of 14 · 269 filings